ULTRACEUTICALS
Ultraceuticals (Fortem Biosciences Pvt. Ltd.) is an AI-powered preclinical drug discovery and pharmaceutical R&D intelligence company.
- Indexed videos, last 90 days
- 4
- Latest publication
- Sep 2, 2026
- Audience
- ~16 subscribers
- Earliest in this view
- Jul 4, 2026
Latest videos
@Razorpayindia Called Us “The Next Big Thing” 🚀 | @ultraceutical (opens the original)
Read excerpt
A moment worth pausing for. Ultraceuticals has been selected by Razorpay Rize as “The Next Big Thing” and featured on a billboard outside Razorpay’s headquarters in Koramangala, Bengaluru. For a small Indian deep-tech team building at the intersection of Artificial Intelligence, Biology and Pharmaceutical R&D, seeing Ultraceuticals on a Bangalore billboard is more than a milestone. It is a reminder of the problem we chose to work on—and the scale of the opportunity ahead. Ultraceuticals is build
AI Won't Wait. Neither Should Pharma Leaders. #pharma #biotech (opens the original)
Read excerpt
Artificial Intelligence is reshaping pharmaceutical R&D at an unprecedented pace. The question is no longer whether AI will influence the pharmaceutical industry—but how quickly organizations will adapt. In this YouTube Short, Prathamesh Walse, Co-Founder and Scientific Lead at Ultraceuticals, shares a message for pharmaceutical R&D leaders, formulation scientists, commercial teams, and decision-makers navigating the future of AI-enabled drug development. The discussion explores how pharmaceutic
Why Every Pharma Company Needs a 360° Scientific Dossier #biotech #drugdiscovery (opens the original)
Read excerpt
Pharmaceutical companies make billion-dollar decisions every year on which molecules to pursue, which generic products to develop, and which opportunities to prioritize. The challenge? Scientific information lives in one place. Patent intelligence lives somewhere else. Commercial insights sit with business teams. Regulatory data is scattered. Leadership often lacks a unified decision framework. In this YouTube Short, Prathamesh Walse introduces the Ultraceuticals 360 Scientific Dossier™—an AI-po
@Razorpayindia Selects Ultraceuticals as a Deep-Tech Startup to Watch (opens the original)
Read excerpt
Pharmaceutical decision-making is becoming increasingly complex. From generics and bioequivalence to regulatory strategy and formulation development, scientists and organizations must navigate enormous volumes of scientific, technical, and regulatory information. This video introduces **Ultraceuticals**, an AI-powered pharmaceutical R&D intelligence company building technologies that help accelerate better scientific decisions through computational biology and artificial intelligence. Our ecosys
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
~16 subscribers
Measured Sep 19, 2026
Source's subscribers, not the number who saw an individual piece.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.